John Boylan
Stock Analyst at William Blair
(2.76)
# 1,789
Out of 5,239 analysts
8
Total ratings
75%
Success rate
19.95%
Average return
Main Sectors:
Stocks Rated by John Boylan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Initiates: Outperform | n/a | $65.95 | - | 1 | Mar 10, 2026 | |
| CI The Cigna Group | Downgrades: Hold | n/a | $298.49 | - | 1 | Aug 18, 2023 | |
| GEHC GE HealthCare Technologies | Initiates: Hold | n/a | $62.29 | - | 1 | Jan 4, 2023 | |
| SYK Stryker | Upgrades: Buy | n/a | $294.45 | - | 1 | Jul 28, 2022 | |
| SYY Sysco | Upgrades: Buy | n/a | $72.98 | - | 2 | Sep 10, 2020 | |
| HSY The Hershey Company | Upgrades: Buy | n/a | $191.91 | - | 2 | Mar 25, 2020 |
BridgeBio Pharma
Mar 10, 2026
Initiates: Outperform
Price Target: n/a
Current: $65.95
Upside: -
The Cigna Group
Aug 18, 2023
Downgrades: Hold
Price Target: n/a
Current: $298.49
Upside: -
GE HealthCare Technologies
Jan 4, 2023
Initiates: Hold
Price Target: n/a
Current: $62.29
Upside: -
Stryker
Jul 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $294.45
Upside: -
Sysco
Sep 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $72.98
Upside: -
The Hershey Company
Mar 25, 2020
Upgrades: Buy
Price Target: n/a
Current: $191.91
Upside: -